TY - JOUR
T1 - Obesity and Cardiac Remodeling in Adults
T2 - Mechanisms and Clinical Implications
AU - Alpert, Martin A.
AU - Karthikeyan, Kamalesh
AU - Abdullah, Obai
AU - Ghadban, Rugheed
N1 - Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/7/1
Y1 - 2018/7/1
N2 - Obesity, particularly severe obesity is capable of producing hemodynamic alterations that contribute to changes in cardiac morphology which may predispose to impairment of ventricular function and heart failure. These include a high cardiac output state in most, left ventricular (LV) hypertrophy, and LV diastolic dysfunction. Right heart involvement may result from LV failure, the hypercirculatory state, and sleep disordered breathing. In recent years experimental studies and some studies in humans suggest that certain neurohormonal and metabolic alterations that occur commonly in obesity may contribute to alterations in cardiac structure and function. These include activation of the renin-angiotensin-aldosterone and sympathetic nervous systems, hyperleptinemia due to leptin resistance, low circulating adiponectin levels, insulin resistance with hyperinsulinemia, and possibly cardiac lipotoxicity. This review will describe the ways in which these factors weave together to promote adaptations and maladaptations that result in alterations in cardiac structure and function which may contribute to the development of heart failure.
AB - Obesity, particularly severe obesity is capable of producing hemodynamic alterations that contribute to changes in cardiac morphology which may predispose to impairment of ventricular function and heart failure. These include a high cardiac output state in most, left ventricular (LV) hypertrophy, and LV diastolic dysfunction. Right heart involvement may result from LV failure, the hypercirculatory state, and sleep disordered breathing. In recent years experimental studies and some studies in humans suggest that certain neurohormonal and metabolic alterations that occur commonly in obesity may contribute to alterations in cardiac structure and function. These include activation of the renin-angiotensin-aldosterone and sympathetic nervous systems, hyperleptinemia due to leptin resistance, low circulating adiponectin levels, insulin resistance with hyperinsulinemia, and possibly cardiac lipotoxicity. This review will describe the ways in which these factors weave together to promote adaptations and maladaptations that result in alterations in cardiac structure and function which may contribute to the development of heart failure.
KW - Cardiac output
KW - Left ventricular diastolic dysfunction
KW - Left ventricular hypertrophy
KW - Metabolic abnormalities
KW - Neurohormonal abnormalities
KW - Obesity
KW - Sleep disordered breathing
UR - http://www.scopus.com/inward/record.url?scp=85051374973&partnerID=8YFLogxK
U2 - 10.1016/j.pcad.2018.07.012
DO - 10.1016/j.pcad.2018.07.012
M3 - Review article
C2 - 29990533
AN - SCOPUS:85051374973
SN - 0033-0620
VL - 61
SP - 114
EP - 123
JO - Progress in cardiovascular diseases
JF - Progress in cardiovascular diseases
IS - 2
ER -